CURB-2, NCT05262270: Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder |
|
|
| Recruiting | 2 | 426 | US | Extended-Release Naltrexone, XR-NTX, Extended Release Buprenorphine, XR-BUP, Placebo (PLB) Injectable matched to XR-NTX, Injectable matching (to XR-NTX) placebo, Placebo (PLB) Injectable matched to XR-BUP, Injectable matching (to XR-BUP) placebo | University of Texas Southwestern Medical Center, National Institute on Drug Abuse (NIDA) | Cocaine Use Disorder | 03/25 | 09/26 | | |
